The Functional Mu Opioid Receptor (OPRM1) Asn40Asp Variant Predicts Short-Term Response to Nicotine Replacement Therapy in a Clinical Trial
Pharmacogenomics Journal - United Kingdom
doi 10.1038/sj.tpj.6500238
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2004
Authors
Publisher
Springer Science and Business Media LLC